The IGHS Group continues its demand for recognition of its work carried out across borders.

IGHS in Uzbekistan
 
The IGHS Group continues its demand for recognition of its work carried out across borders.

Due to the high standards of quality at both technical and human levels that characterise the projects in which the IGHS is involved, an invitation by the Ministry of Health of Uzbekistan to participate in meetings was extended to our group.

This past week, the group’s Chairman, Dr. José Alexandre Cunha, met government and business leaders in the capital Tashkent. Those meetings let bilateral strategies be outlined with the goal of planification and objectively implementing a cluster of different healthcare areas. A priority sector in which this Central Asia country has been working, choosing partners of excellence such as IGHS.

• Innov.Cell ended its successful participation in CPHI 2024

  Innov.Cell, a subsidiary of IGHS, ended its successful participation in CPHI 2024, which took place in Milan, with a positive outcome. This year, CPHI was attended by more than 62,000 people and around 2,400 exhibitors from 166 countries. Throughout the event, Innov.Cell met with several potential partners, from R&D, investors, and distributors covering more than 50 countries.

  Read more
• OIH Introduces Revolutionary Treatment for Keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS)

  Oman International Hospital is thrilled to announce the successful introduction of a groundbreaking procedure designed to treat keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS). This innovative treatment marks a significant advancement in ophthalmology, offering new hope to patients suffering from this debilitating corneal disorder.
   

  Read more